Alzheimer Disease Symptoms: More Than Memory Loss and Confusion
Neuropsychiatric symptoms are now recognized as hallmarks of dementia and are important targets for the development of effective treatments.
New Era Arrives for Disease Modification in Multiple Sclerosis
With more than a dozen available therapies, disease-modification in multiple sclerosis is entering a new era of development.
Searching for Off-Time Relief in Parkinson Disease
Several agents are currently in development geared at the relief of off-time for patients with Parkinson.
Exploring CB1, CB2 in Various Neurological Conditions
Cannabinoids are being explored in a variety of conditions, ranging from Alzheimer disease to migraine.
Phase III Study Brings Hope to ALS
A novel mesenchymal stem cell therapy produced intriguing phase II data and has moved into a randomized, pivotal phase III clinical trial.
Rapid Development of Migraine Therapies Offers New Hope
Physicians offer perspectives on newly approved products to prevent migraine.
